<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="./style.css">
    <title>Document</title>
</head>
<body>
   <div class="main">
        <nav class="main-nav">
            <img style="width: 100px;" src="./image.png" alt="">
            <ul>
                <li>Home</li>
                <li>About</li>
                <li>Gallary</li>
                <li>Contact</li>
            </ul>
        </nav>
   </div>

   <!-- landing page -->
    <div class="overlay">
        <div class="image">
            <div class="overlay">
                <h1 class="about">About Us</h1>
            </div>
        </div>
    </div class="con-about">

     <div class="about-me">
        <p > NeuroNova Company Overview
NeuroNova AB is a pioneering biotechnology company based in Stockholm, Sweden, dedicated to developing transformative therapies for neurodegenerative diseases. Founded in 1998, NeuroNova has built a reputation for innovation in drug discovery, focusing on neurogenesis—the process of generating new neurons in the adult brain—as a therapeutic strategy.
 Mission
To revolutionize the treatment of central nervous system disorders by harnessing the power of neural stem cells and novel molecular targets, addressing conditions with high unmet medical need.
 Core Focus Areas
- Parkinson’s Disease: Development of sNN0031, a promising candidate for moderate to severe stages.
- Amyotrophic Lateral Sclerosis (ALS): Advancement of sNN0029, aimed at slowing disease progression.
- Neurogenesis-Based Therapies: Leveraging adult neural stem cells to regenerate damaged brain tissue.Scientific Innovation
NeuroNova’s research integrates cutting-edge neuroscience with proprietary technologies to develop small molecules and proteins that stimulate brain repair. The company holds over 80 patents, with several active filings targeting the melanocortin 4 receptor—a key player in neural regulation.
Strategic Milestones
- Acquired by Newron Pharmaceuticals in 2012, enabling broader clinical development and commercialization.
- Secured over $19 million in funding, including multiple rounds of venture capital and grants.
- Collaborated with leading institutions and investors such as HealthCap and Novare Kapital.
Headquarters
Fiskartorpsvägen 15 A-D
SE-114 33 Stockholm, Sweden
+46 87 86 09 00
Official Website

Would you like this adapted for a pitch deck, investor summary, or website copy? I can also help with a tagline or vision statement if you're building a brand identity.
   ,An Ai Developer company A month ago, I stepped into something new, something big. I joined the a six-month immersive experience in artificial intelligence, made possible by the visionary support of Dr. Bosun Tijani, Minister of Communications, Innovation and Digital Economy ,Public AI, Ogun state Government, Nigerian Communications Commission.
            I didn’t know exactly what to expect. But from day one, it’s been a whirlwind of learning, growth, and connection. We started with the fundamentals of Python, and already I’ve begun to grasp the building blocks of programming: data types, control flow, functions, OOP, error handling, file operations, and working with libraries like  and Pandas to make sense of data. It’s challenging, yes, but also deeply exciting.
            What’s made this journey even more powerful is the community. I’m surrounded by mentors who genuinely care and peers who push me to think bigger. Every session feels like a step forward, not just in skill, but in confidence.
            I often think about how rare and special this opportunity is. It’s not just a program, it’s a platform. A space where young Nigerians like me are being equipped to shape the future of tech in Africa. And for that, I’m deeply thankful to Dr. Tijani. His belief in our potential and his commitment to digital empowerment is more than inspiring, it’s life-changing.
            There’s still so much ahead. More code to write, more ideas to explore, more solutions to build. But I’m here for it. Fully present. Fully committed.
            This is just the beginning. </p>
        
    </div>
</body>
</html>